Cargando…
The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes
OBJECTIVE: To assess whether glycemic control, soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PlGF) were associated with the development of preeclampsia (PE) or gestational hypertension (GHTN) in women with preexisting diabetes. METHODS: Maternal circulating angiogenic facto...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare USA, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894714/ https://www.ncbi.nlm.nih.gov/pubmed/24354578 http://dx.doi.org/10.3109/10641955.2013.837175 |
_version_ | 1782299883153129472 |
---|---|
author | Cohen, Allison L. Wenger, Julia B. James-Todd, Tamarra Lamparello, Brooke M. Halprin, Elizabeth Serdy, Shanti Fan, Shuling Horowitz, Gary L. Lim, Kee-Hak Rana, Sarosh Takoudes, Tamara C. Wyckoff, Jennifer A. Thadhani, Ravi Karumanchi, S. Ananth Brown, Florence M. |
author_facet | Cohen, Allison L. Wenger, Julia B. James-Todd, Tamarra Lamparello, Brooke M. Halprin, Elizabeth Serdy, Shanti Fan, Shuling Horowitz, Gary L. Lim, Kee-Hak Rana, Sarosh Takoudes, Tamara C. Wyckoff, Jennifer A. Thadhani, Ravi Karumanchi, S. Ananth Brown, Florence M. |
author_sort | Cohen, Allison L. |
collection | PubMed |
description | OBJECTIVE: To assess whether glycemic control, soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PlGF) were associated with the development of preeclampsia (PE) or gestational hypertension (GHTN) in women with preexisting diabetes. METHODS: Maternal circulating angiogenic factors (sFlt1 and PlGF) measured on automated platform were studied at four time points during pregnancy in women with diabetes (N = 159) and reported as multiples of the median (MOM) of sFlt1/PlGF ratio (median, 25th–75th percentile) noted in non-diabetic non-hypertensive control pregnant population (N = 139). Diagnosis of PE or GHTN was determined by review of de-identified clinical data. RESULTS: PE developed in 12% (N = 19) and GHTN developed in 23% (N = 37) of the women with diabetes. Among diabetic women without PE or GHTN, median sFlt1/PlGF levels at 35–40 weeks was threefold higher than in non-diabetic controls [MOM 3.21(1.19–7.24), p = 0.0001]. Diabetic women who subsequently developed PE had even greater alterations in sFlt1/PlGF ratio during the third trimester [MOM for PE at 27–34 weeks 15.18 (2.37–26.86), at 35–40 weeks 8.61(1.20–18.27), p ≤ 0.01 for both windows compared to non-diabetic controls]. Women with diabetes who subsequently developed GHTN also had significant alterations in angiogenic factors during third trimester; however, these findings were less striking. Among women with diabetes, glycosylated hemoglobin (HbA1c) during the first trimester was higher in subjects who subsequently developed PE (7.7 vs 6.7%, p = 0.0001 for diabetic PE vs diabetic non-PE). CONCLUSIONS: Women with diabetes had a markedly altered anti-angiogenic state late in pregnancy that was further exacerbated in subjects who developed PE. Altered angiogenic factors may be one mechanism for the increased risk of PE in this population. Increased HbA1c in the first trimester of pregnancies in women with diabetes was strongly associated with subsequent PE. |
format | Online Article Text |
id | pubmed-3894714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Informa Healthcare USA, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-38947142014-01-22 The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes Cohen, Allison L. Wenger, Julia B. James-Todd, Tamarra Lamparello, Brooke M. Halprin, Elizabeth Serdy, Shanti Fan, Shuling Horowitz, Gary L. Lim, Kee-Hak Rana, Sarosh Takoudes, Tamara C. Wyckoff, Jennifer A. Thadhani, Ravi Karumanchi, S. Ananth Brown, Florence M. Hypertens Pregnancy Original Article OBJECTIVE: To assess whether glycemic control, soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PlGF) were associated with the development of preeclampsia (PE) or gestational hypertension (GHTN) in women with preexisting diabetes. METHODS: Maternal circulating angiogenic factors (sFlt1 and PlGF) measured on automated platform were studied at four time points during pregnancy in women with diabetes (N = 159) and reported as multiples of the median (MOM) of sFlt1/PlGF ratio (median, 25th–75th percentile) noted in non-diabetic non-hypertensive control pregnant population (N = 139). Diagnosis of PE or GHTN was determined by review of de-identified clinical data. RESULTS: PE developed in 12% (N = 19) and GHTN developed in 23% (N = 37) of the women with diabetes. Among diabetic women without PE or GHTN, median sFlt1/PlGF levels at 35–40 weeks was threefold higher than in non-diabetic controls [MOM 3.21(1.19–7.24), p = 0.0001]. Diabetic women who subsequently developed PE had even greater alterations in sFlt1/PlGF ratio during the third trimester [MOM for PE at 27–34 weeks 15.18 (2.37–26.86), at 35–40 weeks 8.61(1.20–18.27), p ≤ 0.01 for both windows compared to non-diabetic controls]. Women with diabetes who subsequently developed GHTN also had significant alterations in angiogenic factors during third trimester; however, these findings were less striking. Among women with diabetes, glycosylated hemoglobin (HbA1c) during the first trimester was higher in subjects who subsequently developed PE (7.7 vs 6.7%, p = 0.0001 for diabetic PE vs diabetic non-PE). CONCLUSIONS: Women with diabetes had a markedly altered anti-angiogenic state late in pregnancy that was further exacerbated in subjects who developed PE. Altered angiogenic factors may be one mechanism for the increased risk of PE in this population. Increased HbA1c in the first trimester of pregnancies in women with diabetes was strongly associated with subsequent PE. Informa Healthcare USA, Inc. 2014-02 2013-12-19 /pmc/articles/PMC3894714/ /pubmed/24354578 http://dx.doi.org/10.3109/10641955.2013.837175 Text en © 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited. |
spellingShingle | Original Article Cohen, Allison L. Wenger, Julia B. James-Todd, Tamarra Lamparello, Brooke M. Halprin, Elizabeth Serdy, Shanti Fan, Shuling Horowitz, Gary L. Lim, Kee-Hak Rana, Sarosh Takoudes, Tamara C. Wyckoff, Jennifer A. Thadhani, Ravi Karumanchi, S. Ananth Brown, Florence M. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes |
title | The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes |
title_full | The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes |
title_fullStr | The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes |
title_full_unstemmed | The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes |
title_short | The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes |
title_sort | association of circulating angiogenic factors and hba1c with the risk of preeclampsia in women with preexisting diabetes |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894714/ https://www.ncbi.nlm.nih.gov/pubmed/24354578 http://dx.doi.org/10.3109/10641955.2013.837175 |
work_keys_str_mv | AT cohenallisonl theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT wengerjuliab theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT jamestoddtamarra theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT lamparellobrookem theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT halprinelizabeth theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT serdyshanti theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT fanshuling theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT horowitzgaryl theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT limkeehak theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT ranasarosh theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT takoudestamarac theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT wyckoffjennifera theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT thadhaniravi theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT karumanchisananth theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT brownflorencem theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT cohenallisonl associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT wengerjuliab associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT jamestoddtamarra associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT lamparellobrookem associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT halprinelizabeth associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT serdyshanti associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT fanshuling associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT horowitzgaryl associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT limkeehak associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT ranasarosh associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT takoudestamarac associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT wyckoffjennifera associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT thadhaniravi associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT karumanchisananth associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes AT brownflorencem associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes |